Atlas Trials

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Clinical trial NCT02208037 · COMPLETED

Trial details

NCT number
NCT02208037
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasiaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoma, B-CellLymphoma, FollicularLymphoma, Large B-Cell, DiffuseHodgkin's Lymphoma
Start date
2014-08-01
Primary completion
2017-10-01
Enrollment
279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.